Skip to main content
letter
. 2022 Apr 8;41(5):e249–e251. doi: 10.1097/INF.0000000000003482

TABLE 1.

Comparison Between Features of Ambulatory Children Attended During the Omicron Wave and Previous Waves at the Emergency Rooms

Features Previous Waves N = 546 (%) Omicron Wave N = 109 (%) P
Sex (female) 289 (52.9%) 60 (55.0%) 0.686
Age (yrs), median (IQR) 5.7 (1.1–11.7) 6.6 (1.3–9.8) 0.330
Age band (yrs) <0.001
 0–4 259 (47.4%) 47 (43.1%)
 5–12 162 (29.7%) 54 (49.5%)
 12 or above 125 (22.9%) 8 (7.3%)
Comorbidity 99 (18.1%) 12 (11.0%) 0.070
Contact with household confirmed case 240 (44.0%) 33 (30.3%) 0.008
Symptoms/signs
 Fever 371 (67.9%) 90 (82.6%) 0.002
 Cough 264 (48.4%) 61 (56.0%) 0.147
 Sore throat 99 (18.1%) 20 (18.3%) 0.957
 Runny nose 197 (36.1%) 49 (45.0%) 0.081
 Fatigue, malaise 73 (12.2%) 12 (11.0%) 0.728
 Wheezing 23 (4.2%) 2 (1.8%) 0.237
 Headache 88 (16.1%) 35 (32.1%) <0.001
 Myalgia 48 (8.8%) 4 (3.7%) 0.071
 Diarrhea 75 (13.7%) 23 (21.1%) 0.049
 Vomiting 91 (16.7%) 23 (21.1%) 0.265
Syndromic diagnosis*
 Upper respiratory tract infection 195 (37.0%) 73 (67.0%) <0.001
 Flu-like 80 (15.2%) 14 (12.8%) 0.532
 Fever without a source 84 (15.9%) 5 (4.6%) 0.002
 Gastroenteritis 40 (7.6%) 7 (6.4%) 0.671
 Pneumonia 38 (7.2%) 1 (0.9%) 0.013
 Asymptomatic 44 (8.3%) 3 (2.8%) 0.042
 Bronchitis/asthma flare 18 (3.4%) 2 (1.8%) 0.389
 Bronchiolitis 2 (0.4%) 0 (0.0%) 0.519

Categorical variables are compared using the χ2 or Fisher tests, and continuous variables using Wilcoxon rank-sum test. Significant P values (<0.05) are in bold.

*

The syndromic diagnosis was not recorded in 19 cases diagnosed in previous waves; percentages and P values are calculated omitting those cases.